Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 1/2a Study of BMS-986178 Administered Alone and in Combination With Nivolumab or Ipilimumab in Advanced Solid Tumors
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.